APA (7th ed.) Citation

Papaelias, A., Lidington, D., & Bolz, S. (2025, June 23). Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects. Drugs in R&D. https://doi.org/10.1007/s40268-025-00514-9

Chicago Style (17th ed.) Citation

Papaelias, Alexandra, Darcy Lidington, and Steffen-Sebastian Bolz. "Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects." Drugs in R&D 23 Jun. 2025. https://doi.org/10.1007/s40268-025-00514-9.

MLA (9th ed.) Citation

Papaelias, Alexandra, et al. "Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects." Drugs in R&D, 23 Jun. 2025, https://doi.org/10.1007/s40268-025-00514-9.